2-((1-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)-N-(o-tolyl)benzamide

ID: ALA4093700

PubChem CID: 137655403

Max Phase: Preclinical

Molecular Formula: C30H33N5O4

Molecular Weight: 527.63

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)CN(CCn1cc(COc3ccccc3C(=O)Nc3ccccc3C)nn1)CC2

Standard InChI:  InChI=1S/C30H33N5O4/c1-21-8-4-6-10-26(21)31-30(36)25-9-5-7-11-27(25)39-20-24-19-35(33-32-24)15-14-34-13-12-22-16-28(37-2)29(38-3)17-23(22)18-34/h4-11,16-17,19H,12-15,18,20H2,1-3H3,(H,31,36)

Standard InChI Key:  BXJYOCWGNNBSDR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    1.4761  -19.9138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4750  -20.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1872  -21.1465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9009  -20.7370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8981  -19.9102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1854  -19.5009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6134  -21.1445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6147  -21.9658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3205  -20.7348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0330  -21.1423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6084  -19.4949    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3177  -19.9049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0279  -19.4895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7773  -19.8262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3260  -19.2127    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9106  -18.5023    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1078  -18.6754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1442  -19.2122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5524  -18.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3738  -18.4998    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7835  -19.2177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6013  -19.2192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7816  -17.7924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6056  -17.7956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0104  -18.5104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8307  -18.5141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2470  -17.8038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8330  -17.0882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0141  -17.0879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2461  -16.3766    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0683  -17.8061    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4749  -18.5190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0674  -16.3771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0296  -21.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7413  -22.3736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4534  -21.9597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4495  -21.1342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7373  -20.7305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3209  -22.3690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  5 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 23  1  0
 21 22  1  0
 22 25  1  0
 24 23  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 28 30  1  0
 27 31  1  0
 31 32  1  0
 30 33  1  0
 10 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 10  1  0
 34 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4093700

    ---

Associated Targets(Human)

K562/A02 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 527.63Molecular Weight (Monoisotopic): 527.2533AlogP: 4.49#Rotatable Bonds: 10
Polar Surface Area: 90.74Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.14CX LogP: 4.74CX LogD: 4.55
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.32Np Likeness Score: -1.58

References

1. Pan M, Cui J, Jiao L, Ghaleb H, Liao C, Zhou J, Kairuki M, Lin H, Huang W, Qian H..  (2017)  Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.,  25  (15): [PMID:28645831] [10.1016/j.bmc.2017.06.015]

Source